Free Trial

Atossa Therapeutics (ATOS) Earnings Date, Estimates & Call Transcripts

Atossa Therapeutics logo
$1.41
-0.01 (-0.70%)
(As of 11/4/2024 ET)

Atossa Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 11Estimated
Actual EPS
(Aug. 12)
-$0.05 Beat By $0.01
Consensus EPS
(Aug. 12)
-$0.06

Atossa Therapeutics released Q2 2024 earnings on August 12, 2024, reporting an EPS of -$0.05, which topped analysts' consensus estimates of -$0.06 by $0.01. With a trailing EPS of -$0.21, Atossa Therapeutics' earnings are expected to decrease next year, from ($0.22) to ($0.27) per share.

ATOS Upcoming Earnings

Atossa Therapeutics' next earnings date is estimated for Monday, November 11, 2024, based off prior year's reporting schedules.

Get Atossa Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Atossa Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ATOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATOS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Atossa Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.07-$0.07-$0.07
Q2 20241-$0.05-$0.05-$0.05
Q3 20241-$0.05-$0.05-$0.05
Q4 20241-$0.06-$0.06-$0.06
FY 20244($0.23)($0.23)($0.23)

Atossa Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/11/2024
(Estimated)
------- 
8/12/2024Q2 2024-$0.06-$0.05+$0.01-$0.05--  
5/13/2024--$0.07-$0.05+$0.02-$0.05--  
4/1/2024Q4 2023--$0.06 -$0.06-$0.06--  
11/13/2023Q3 2023--$0.05 -$0.05-$0.05--  
8/14/2023Q2 2023-$0.06-$0.06--$0.04--      
5/15/2023Q1 2023--$0.05 -$0.05-$0.05--  
3/22/2023Q4 2022--$0.06 -$0.06-$0.06--  
11/7/2022Q3 2022--$0.06 -$0.06-$0.06--

Atossa Therapeutics Earnings - Frequently Asked Questions

Atossa Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on ATOS's earnings history.

In the previous quarter, Atossa Therapeutics (NASDAQ:ATOS) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $0.01. Learn more on analysts' earnings estimate vs. ATOS's actual earnings.

Atossa Therapeutics (NASDAQ:ATOS) has a recorded net income of -$30.09 million. ATOS has generated -$0.21 earnings per share over the last four quarters.

Atossa Therapeutics's earnings are expected to decrease from ($0.22) per share to ($0.27) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:ATOS) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners